ATE115187T1 - Poxvirus-vektoren. - Google Patents
Poxvirus-vektoren.Info
- Publication number
- ATE115187T1 ATE115187T1 AT89902719T AT89902719T ATE115187T1 AT E115187 T1 ATE115187 T1 AT E115187T1 AT 89902719 T AT89902719 T AT 89902719T AT 89902719 T AT89902719 T AT 89902719T AT E115187 T1 ATE115187 T1 AT E115187T1
- Authority
- AT
- Austria
- Prior art keywords
- promoter
- fpv
- virus
- expression
- fowlpox
- Prior art date
Links
- 239000013598 vector Substances 0.000 title abstract 2
- 241000700662 Fowlpox virus Species 0.000 abstract 7
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 241000271566 Aves Species 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 244000144977 poultry Species 0.000 abstract 1
- 230000002123 temporal effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compression Or Coding Systems Of Tv Signals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPI672188 | 1988-02-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE115187T1 true ATE115187T1 (de) | 1994-12-15 |
Family
ID=3772810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89902719T ATE115187T1 (de) | 1988-02-12 | 1989-02-10 | Poxvirus-vektoren. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5258294A (de) |
| EP (1) | EP0414689B1 (de) |
| JP (1) | JPH03503482A (de) |
| AT (1) | ATE115187T1 (de) |
| AU (1) | AU611263B2 (de) |
| CA (1) | CA1341251C (de) |
| DE (1) | DE68919846T2 (de) |
| NZ (1) | NZ227934A (de) |
| WO (1) | WO1989007644A1 (de) |
| ZA (1) | ZA891067B (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7767449B1 (en) | 1981-12-24 | 2010-08-03 | Health Research Incorporated | Methods using modified vaccinia virus |
| US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
| US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| FR2632863B2 (fr) * | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
| US5631154A (en) * | 1988-06-10 | 1997-05-20 | Therion Biologics, Incorporated | Self assembled, defective, non-self-propagating lentivirus particles |
| US5093258A (en) * | 1988-08-26 | 1992-03-03 | Therion Biologics Corporation | Recombinant fowlpox virus and recombination vector |
| AU634773B2 (en) * | 1989-05-08 | 1993-03-04 | Basil Arif | Spheroidin dna isolate and recombinant entomopoxvirus expression vectors |
| US5162222A (en) * | 1989-07-07 | 1992-11-10 | Guarino Linda A | Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses |
| GB8915870D0 (en) * | 1989-07-11 | 1989-08-31 | Nat Res Dev | Dna coding for a polypeptide signal sequence in vaccinia virus |
| US5169784A (en) * | 1990-09-17 | 1992-12-08 | The Texas A & M University System | Baculovirus dual promoter expression vector |
| AU6299594A (en) * | 1993-02-26 | 1994-09-14 | Nippon Zeon Co., Ltd. | Recombinant fowlpox virus s-fpv-043 and uses thereof |
| US5925358A (en) * | 1993-02-26 | 1999-07-20 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
| US6136318A (en) * | 1993-02-26 | 2000-10-24 | Cochran; Mark D. | Recombinant fowlpox viruses and uses thereof |
| EP0832197A4 (de) * | 1995-06-07 | 2002-10-16 | Syntro Corp | Rekombinantes geflügelpockenvirus und seine verwendungsmöglichkeiten |
| US7351578B2 (en) * | 1999-12-10 | 2008-04-01 | Invitrogen Corp. | Use of multiple recombination sites with unique specificity in recombinational cloning |
| EP1025217B1 (de) | 1997-10-24 | 2006-10-04 | Invitrogen Corporation | Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen |
| US20030138808A1 (en) * | 1998-02-19 | 2003-07-24 | Simard John J.L. | Expression vectors encoding epitopes of target-associated antigens |
| EP1173460B1 (de) | 1999-03-02 | 2009-09-16 | Life Technologies Corporation | Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren |
| US6388170B1 (en) | 2000-04-07 | 2002-05-14 | University Of Kentucky Research Foundation | Bidirectional promoters and methods related thereto |
| US6861234B1 (en) | 2000-04-28 | 2005-03-01 | Mannkind Corporation | Method of epitope discovery |
| US20030215425A1 (en) * | 2001-12-07 | 2003-11-20 | Simard John J. L. | Epitope synchronization in antigen presenting cells |
| DK1276896T3 (da) * | 2000-04-28 | 2010-10-18 | Mannkind Corp | Epitop-synkronisering i antigen-præsenterende celler |
| US7198924B2 (en) | 2000-12-11 | 2007-04-03 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| EP1360310A2 (de) * | 2001-02-13 | 2003-11-12 | University Of Florida | Bidirektionaler dualer promotorkomplex mit verstärkter promotoraktivität zur transgenen expression in eukaroynten |
| GB0109515D0 (en) * | 2001-04-17 | 2001-06-06 | Neg Micon As | A method for transporting a set of large longitudinal items, a package system to be used by the method and use of such a package system |
| EP1281767A3 (de) * | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Lichtausstrahlende Mikroorganismen und Zellen für die Diagnose und Therapie von Tumoren |
| CN101024842A (zh) * | 2001-11-07 | 2007-08-29 | 曼康公司 | 编码靶相关抗原表位的表达载体及其设计方法 |
| ATE420160T1 (de) | 2003-06-18 | 2009-01-15 | Genelux Corp | Modifizierte rekombinante vacciniaviren, verwendungen davon |
| WO2005054438A2 (en) | 2003-12-01 | 2005-06-16 | Invitrogen Corporation | Nucleic acid molecules containing recombination sites and methods of using the same |
| EP2097517B1 (de) | 2006-10-16 | 2014-06-04 | Genelux Corporation | Rekombinantes Lister-Stamm Vaccinia Virus kodierend für einen einzelkettigen anti-VEGF Antikörper |
| BRPI0812124A2 (pt) * | 2007-05-30 | 2014-10-14 | Wyeth Llc | Poxviridae de guaxinim expressando genes de vírus suíno |
| CA2690627C (en) * | 2007-06-15 | 2014-12-02 | Genelux Corporation | Microorganisms for imaging and/or treatment of tumors |
| JP2010533718A (ja) * | 2007-07-18 | 2010-10-28 | ジェネラックス・コーポレイション | 腫瘍溶解性ウイルス治療に付随する副作用の処置もしくは改善用医薬の製造における化学治療剤の使用 |
| WO2009054996A2 (en) * | 2007-10-25 | 2009-04-30 | Genelux Corporation | Systems and methods for viral therapy |
| GB201006405D0 (en) * | 2010-04-16 | 2010-06-02 | Isis Innovation | Poxvirus expression system |
| EP2591113B1 (de) * | 2010-07-07 | 2016-01-20 | Daiichi Sankyo Company, Limited | Dna-element mit wirkung zur verstärkung fremder gene |
| ES2733211T3 (es) | 2011-04-15 | 2019-11-28 | Genelux Corp | Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| AU570940B2 (en) * | 1982-11-30 | 1988-03-31 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Process for producing poxvirus recombinants for expression offoreign genes |
| AU605567B2 (en) * | 1987-03-11 | 1991-01-17 | Nippon Zeon Co., Ltd. | Recombinant avipoxvirus |
| CA1340203C (en) * | 1987-09-16 | 1998-12-15 | Noboru Yanagida | Recombinant apivoxvirus |
| EP0404835A4 (en) * | 1988-03-18 | 1991-05-08 | Us Health | Novel recombinant vaccinia virus expression vectors and method of selecting same |
| ZA902147B (en) * | 1989-03-28 | 1990-12-28 | Akzo Nv | Coccidiosis vaccine |
-
1989
- 1989-02-10 DE DE68919846T patent/DE68919846T2/de not_active Expired - Lifetime
- 1989-02-10 ZA ZA891067A patent/ZA891067B/xx unknown
- 1989-02-10 AU AU30698/89A patent/AU611263B2/en not_active Expired
- 1989-02-10 WO PCT/AU1989/000055 patent/WO1989007644A1/en not_active Ceased
- 1989-02-10 JP JP1502516A patent/JPH03503482A/ja active Pending
- 1989-02-10 NZ NZ227934A patent/NZ227934A/en unknown
- 1989-02-10 AT AT89902719T patent/ATE115187T1/de active
- 1989-02-10 CA CA000590802A patent/CA1341251C/en not_active Expired - Lifetime
- 1989-02-10 EP EP89902719A patent/EP0414689B1/de not_active Expired - Lifetime
- 1989-02-10 US US07/582,881 patent/US5258294A/en not_active Expired - Lifetime
-
1992
- 1992-12-18 US US07/993,073 patent/US5368855A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5258294A (en) | 1993-11-02 |
| EP0414689A4 (en) | 1991-05-22 |
| WO1989007644A1 (en) | 1989-08-24 |
| ZA891067B (en) | 1990-04-25 |
| AU611263B2 (en) | 1991-06-06 |
| US5368855A (en) | 1994-11-29 |
| AU3069889A (en) | 1989-09-06 |
| EP0414689B1 (de) | 1994-12-07 |
| DE68919846D1 (de) | 1995-01-19 |
| JPH03503482A (ja) | 1991-08-08 |
| DE68919846T2 (de) | 1995-07-06 |
| NZ227934A (en) | 1991-06-25 |
| EP0414689A1 (de) | 1991-03-06 |
| CA1341251C (en) | 2001-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68919846D1 (de) | Poxvirus-vektoren. | |
| DK11789A (da) | Rekombinante vaccinia-vira | |
| AR003425A1 (es) | Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv) | |
| BR9306984A (pt) | Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo | |
| DE3888086D1 (de) | Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine. | |
| ATE144552T1 (de) | Rekombinantes geflügelpockenvirus | |
| ECSP23016688A (es) | Terapia génica mediante constructos de ácido nucleico que comprenden secuencias promotoras de la proteína de unión a metil cpg 2 (mecp2) | |
| DE69534600D1 (de) | Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus | |
| DK1253201T3 (da) | Kyllingeanæmivirusmutanter og vacciner baseret på det virale protein VP3 eller sekvenser af dette virus kodende derfor | |
| BR9710975A (pt) | Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis | |
| KR890700030A (ko) | 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 | |
| EP0236977A3 (de) | Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera | |
| KR900701291A (ko) | 혈호균속 인플루엔자용 백신과 진단검사법 | |
| DE3776034D1 (de) | Vakzine. | |
| NO874704L (no) | Minaktivin fremstilt ved rekombinant dna-teknikk. | |
| BR9508645B1 (pt) | seqÜÊncia de nucleotÍdeos isolada compreendendo o gene s fipv tendo uma seqÜencia de nucleotÍdeos da cepa 79-1146 fipv, bem como polipeptÍdeo, vacina e composiÇço compreendendo a mesma. | |
| DE3877136D1 (de) | Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung. | |
| NO942075L (no) | Rekombinante virus omfattende kunstig proteolytisk spaltingssete | |
| DE69019092D1 (de) | Von Babesia abgeleitete Antigene und Polypeptide (12D3-Antigen). | |
| BR0210937A (pt) | Receptor acoplado à proteìna g, gave 3 | |
| TH64168B (th) | รีคอมบิแนนท์ bcg วัคซีน |